Welcome to Precision Vaccinations News
WEBLatest Vaccine Breaking News. 13% of Vaccinated Children Died From InfluenzaPediatric influenza deaths influenced by vaccination timing, medical condition, hospital access. Influenza. Palm Beach Now Under Mosquito-Borne Illness AdvisoryChikungunya, Dengue, Malaria travel vaccines offered in 2024. Dengue.
Vaccine News — Precision Vaccinations News
WEBVaccine news brought to you by Precision Vaccinations. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the companies’ Omicron KP.2-adapted monovalent COVID-19 vaccine (COMIRNATY ® KP.2) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older.
mRNA-1608 Herpes Vaccine - Precision Vaccinations News
WEBFeb 18, 2022 · mRNA-1608 Herpes Vaccine Candidate Clinical Trials, Dosage, Indication, News, Side Effects. Moderna Inc.'s herpes simplex virus vaccine candidate is a Messenger RNA () vaccine targeted against HSV-2 disease.On February 18, 2022, Moderna Inc. stated that it expects an HSV-2 vaccine could provide cross-protection against HSV-1. With mRNA-1608, Moderna aims to induce a strong antibody response ...
Herpes Vaccine Candidates — Precision Vaccinations News
WEBSep 12, 2024 · Women comprise up to 65% of infections in the United States and worldwide. As of September 12, 2024, herpes vaccine candidates conducting clinical trials include: mRNA-1608 is an mRNA vaccine candidate against HSV-2 disease. The mRNA-1608-P101 phase 1 study launched on September 6, 2023, and is forecasted to be completed on June 4, 2025.
HSV Treatment Readies for Approval — Precision Vaccinations News
WEBMar 29, 2023 · A recently published Original Article reported positive news regarding the First-in-Human clinical trials assessing Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor targeting the Herpes Simplex Virus (HSV). As an active ingredient in a new chemical class (thiazolylamides), Pritelivir is active against both types of …
CoviShield COVID-19 Vaccine - Precision Vaccinations News
WEBMay 6, 2024 · CoviShield™ COVID-19 Vaccine Clinical Trials, Dosage, Indication, Side Effects. AstraZeneca CoviShield™ COVID-19 (C19VAZ) vaccine is made from the ChAdOx1 virus, a weakened version of a common cold virus ().In addition, genetic material has been added to the ChAdOx1 construct, which is used to make proteins from the SARS-CoV-2 coronavirus called Spike glycoprotein (S).
Multi-Country Herpes Immunotherapy Clinical Study Continues
WEBMar 5, 2024 · This multi-country research study is recruiting 332 healthy participants aged 18-40 years or those aged 18-60 years with recurrent genital herpes. Known as GSK3943104A, GSK Study #215336 is forecasted to conclude in May 2026. This HSVTI study will explore different formulations and be conducted in two parts:
Herpes Vaccine Candidate Advances in 2023 - Precision …
WEBJan 8, 2023 · When BioNTech SE announced that the first person was dosed in a first-in-human Phase 1 clinical trial with BNT163, a herpes simplex virus (HSV) vaccine candidate for the prevention of genital lesions caused by HSV-2 and potentially HSV-1, there was much enthusiasm generated by millions of people. BioNTech's placebo-controlled, observer-blinded, two-dose-escalation study was launched on ...
Preconception Malaria Immunization Found Safe
WEBAug 21, 2024 · The U.S. National Institutes of Health (NIH) recently supported clinical trials of an experimental malaria vaccine in adults and found that all three tested regimens were safe. One of the trials enrolled healthy women who anticipated becoming pregnant soon after immunization. That trial began with drug treatment to remove malaria parasites ...
mRNA-Based Flu Shot Focuses on Improving Performance in …
WEBApril 4, 2024 • 9:47 am CDT. As influenza vaccine producers prepare for the 2024 - 2025 flu season, innovative vaccine candidates are progressing in clinical research, focused on enhancing efficacy and safety. CureVac N.V. today announced interim data from an ongoing Phase 2 study, which is part of the combined Phase 1/2 study of its seasonal ...